Representative Publications and Research Links
-
Dodson, W.W., Modestino, E.J., Titiz-Ceritoğlu, H., & Zayed, B. (2024) Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series. Acta Scientific Neurology, 7(8): 23-30. DOI: 10.31080/ASNE.2024.07.0762
-
Modestino, E.J., Bowirrat A, Baron, D., Thanos, P.K., Hanna, C., Bagchi, D., Braverman, E.R., Dennen, C.A., Badgaiyan, R.D., Pollack, A.R., Lewandrowski, K.-U., Sharafshah, A., Gold, M.S., & Blum, K. (2024) Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs. J Addict Psychiatry, 8(1): 34-49
-
Modestino, E.J., Bowirrat, A., Lewandowski, K.-U., Sharafshah, A., Badgaiyan, R.D., Thanos, P.K., Baron, D., Dennen, C.A., Elman, I., Sunder, K., Murphy, K.T., & Blum, K. (2024). Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss. Acta Scientific Neurology, 7(5): 12-18. DOI: 10.31080/ASNE.2024.07.0731
-
Dodson, W.W., & Modestino, E.J. (2024). Have we placed the cart before the horse by using alpha-2A agonists to treat rejection sensitivity dysphoria in ADHD? Current Psychopharmacology, e050424228696. DOI: 10.2174/0122115560297397240404071044
-
Modestino, E. J., Blum, K., Dennen, C. A., Downs, B. W., Bagchi, D., Llanos-Gomez, L., Elman, I., Baron, D., Thanos, P. K., Badgaiyan, R. D., Braverman, E. R., Gupta, A., Gold, M. S., & Bowirrat, A. (2022). Theorizing the role of dopaminergic polymorphic risk alleles with intermittent explosive disorder (IED), violent/aggressive behavior and addiction: Justification of genetic addiction risk severity (GARS) testing. Journal of Personalized Medicine, 12(12), 1946. https://doi.org/10.3390/jpm12121946
-
Steinberg, B., Carey, E., Modestino, E.J., Lubar, J., Thanos, P.K, Baron, D., & Blum, K. (2019) Pro-dopamine regulation with KB220Z improves working memory in an adult with ADHD—A case report and replication. Open Journal of Clinical & Medical Case Reports. 5(2):1512. https://jclinmedcasereports.com/articles/OJCMCR-1512.pdf
-
Modestino, E.J., Reinhofer, A., Blum, K., Amenechi, C. & O’Toole, P. (2018). Hoehn and Yahr staging of Parkinson’s disease in relation to neuropsychological measures. Frontiers in Bioscience, 23(7), 1370–1379. https://doi.org/10.2741/4649
-
Modestino, E. J., Amenechi, C., Reinhofer, A., & O’Toole, P. (2016). Side‐of‐onset of Parkinson’s disease in relation to neuropsychological measures. Brain and Behavior, 7(1). https://doi.org/10.1002/brb3.590
-
Modestino, E.J., O’Toole, P., & Reinhofer, A. (2016). Experiential and doctrinal religious knowledge categorization in Parkinson’s disease: Behavioral and brain correlates. Frontiers in Human Neuroscience, 10. https://doi.org/10.3389/fnhum.2016.00113
-
Modestino, E. J. (2016). Neurophenomenology of an altered state of consciousness: An fMRI case study. EXPLORE: The Journal of Science & Healing, 12(2), 128–135. https://doi.org/10.1016/j.explore.2015.12.004
-
Modestino, E. J., Blum, K., Oscar-Berman, M., Gold, M. S., Duane, D. D., Sultan, S. G. S., & Auerbach, S. H. (2015). Reward deficiency syndrome: Attentional/arousal subtypes, limitations of current diagnostic nosology, and future research. Journal of Reward Deficiency Syndrome, 01(01). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545661/pdf/nihms-692690.pdf
-
Modestino, E.J., & Winchester, J. (2013). A retrospective survey of childhood ADHD symptomatology among Adult Narcoleptics. Journal of Attention Disorders, 17(7), 574-582. https://doi.org/10.1177/1087054713480033
Dr. Modestino's Doctoral Dissertation
“The Neural Correlates of Endogenously Cued Covert Visuospatial Attentional Shifting in the Cue-Target Interval: An Electroencephalographic Study."
Dr. Modestino’s Scientific Journal Appointments:
-
Associate Editor for the Journal of Addiction Science
-
Editorial Board Member for Brain Sciences in the Behavioral Neuroscience section
-
Editorial Board Member for Current Psychopharmacology
-
Editorial Board of the Journal of Personalized Medicine
-
Editorial Board Member of INNOSC Theranostics and Pharmacological Sciences (ITPS)